Welcome to LookChem.com Sign In|Join Free
  • or
1-Piperidinyloxy, 2,2,6,6-tetramethyl-4-(phenylmethoxy)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

31645-22-4

Post Buying Request

31645-22-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

31645-22-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 31645-22-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,1,6,4 and 5 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 31645-22:
(7*3)+(6*1)+(5*6)+(4*4)+(3*5)+(2*2)+(1*2)=94
94 % 10 = 4
So 31645-22-4 is a valid CAS Registry Number.

31645-22-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-benzyloxy-2,2,6,6-tetramethylpiperidine-1-oxyl

1.2 Other means of identification

Product number -
Other names 4-BENZYLOXY TEMPO

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:31645-22-4 SDS

31645-22-4Relevant academic research and scientific papers

Nickel-Catalyzed Aminoxylation of Inert Aliphatic C(sp3)-H Bonds with Stable Nitroxyl Radicals under Air: One-Pot Route to α-Formyl Acid Derivatives

Wang, Chunxia,Zhang, Luoqiang,You, Jingsong

supporting information, p. 1690 - 1693 (2017/04/11)

Nickel-catalyzed aminoxylation of an unactivated C(sp3)-H bond with a stable nitroxyl radical has been accomplished for the first time to offer various N-alkoxyamine derivatives, which further enables a one-pot approach to α-formyl acid derivatives. The aminoxylation process reported also provides direct evidence for the oxidative addition of a cyclometallic intermediate with a free radical, which is helpful for the reaction-mechanism study in transition-metal-catalyzed functionalization of inert C(sp3)-H bonds.

THE USE OF STABLE LIPOPHILIC HYDROXYLAMINE COMPOUNDS FOR INHIBITING POLYMERIZATION OF VINYL MONOMERS

-

Page/Page column 12; 13, (2016/10/04)

The present invention generally relates to compounds and methods for inhibiting the radical polymerization of unsaturated compounds, particularly vinyl monomers. More particularly, it relates to the use of stable hydroxyl amines to inhibit the polymerization of unsaturated compounds (e.g., vinyl monomers) wherein said stable hydroxylamine is soluble in organic solvents, particularly hydrocarbon solvents consisting of unsaturated and, therefore, polymerizable constituents.

A novel protecting group methodology for syntheses using nitroxides

Chalmers, Benjamin A.,Morris, Jason C.,Fairfull-Smith, Kathryn E.,Grainger, Richard S.,Bottle, Steven E.

supporting information, p. 10382 - 10384 (2013/10/22)

The methoxyamine group represents an ideal protecting group for the nitroxide moiety. It can be easily and selectively introduced in high yield (typically >90%) to a range of functionalised nitroxides using FeSO 4·7H2O and H2O2 in DMSO. Its removal is readily achieved under mild conditions in high yield (70-90%) using mCPBA in a Cope-type elimination process.

HYDROXYLAMINE COMPOUNDS AND METHODS OF THEIR USE

-

Page/Page column 78, (2008/12/08)

The present disclosure provides compounds that include hydroxylamines of formula (I) or (II), pharmaceutical compositions, and methods for their use. The methods utilize hydroxylamine compounds and/or their pharmaceutical compositions for the treatment of angiogenesis, hepatitis, complement-mediated pathologies, drusen-mediated pathologies, macular degeneration and certain other ophthalmic conditions, inflammation, arthritis, and related diseases and for the inhibition of complement activation.

Drug Resistance Reversal In Neoplastic Disease

-

Page/Page column 35, (2008/12/08)

The present invention is directed to compounds, compositions, and methods for halting or reversing the effects of chemoresistance in neoplastic diseases. In particular the use of hydroxylamines is described.

Synthesis and enzyme-catalyzed hydrolysis of a radical-masked glycosylated spin-label reagent

Sato, Shingo,Nemoto, Miho,Kumazawa, Toshihiro,Matsuba, Shigeru,Onodera, Jun-Ichi,Aoyama, Masaaki,Obara, Heitaro,Kamada, Hitoshi

, p. 2425 - 2432 (2007/10/03)

N1-Acetoxy-2,2,6,6-tetramethylpiperidin-4-yl 2,3,4,6-tetra-O-benzyl-α- and -β-d-glucopyranosides (3-α, β) and N1-acetoxy-2,2,5,5-tetramethylpyrrolin-3-oyl 2,3,4,6-tetra-O-benzyl-α- and -β-d-glucopyranosylamines (9-α, β) were synthesized in good yield by Schmidt's glycosylation method. Their subsequent O-debenzylation was proceeded successfully to give the desired products 1-α, and 1-β in good yield, and 2-α in a low yield, without 2-β by only short-timed hydrogenolysis in the presence of palladium-on-carbon (Pd-C) in a CHCl3-MeOH solvent system that included concentrated HCl. Upon enzyme-catalyzed hydrolysis, only 2-α was hydrolyzed by the esterase, while both of 1-α and 1-β were not hydrolyzed by any other enzyme such as lipase. These 2-α can likely be used as a new water-soluble radical-masked glycosylated spin-label reagent.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 31645-22-4